GFAP and early-onset autosomal dominant Alzheimer disease: Elevated GFAP expression is likely involved in the pathogenesis of neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis (Palmer and Ousman, 2018).